Rothwell Investment Advisors, LLC’s Amphastar Pharmaceuticals AMPH Stock Holding History

Rothwell Investment Advisors, LLC’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$30.5K	Buy	+1,180	New	+$25.5K	0.02%	523

Other funds holding AMPH

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Bridge City Capital Lake Oswego, Oregon $480M AUM 47.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.3B AUM 33.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

LAM Group Lake Oswego, Oregon $199M AUM 14.21% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Rothwell Investment Advisors, LLC's AMPH Position: Q3 2026 in Review

Rothwell Investment Advisors, LLC opened a new position in Amphastar Pharmaceuticals (AMPH) in Q3 2026: 1,180 shares worth $30.5K. The stake represents 0.02% of the portfolio and ranks #523 among its holdings.

119 funds tracked by Wall St. Rank hold AMPH as of Q3 2026.

Rothwell Investment Advisors, LLC held 1,180 shares of Amphastar Pharmaceuticals worth $30.5K as of Q3 2026.
Amphastar Pharmaceuticals was a new Rothwell Investment Advisors, LLC position in Q3 2026.
Amphastar Pharmaceuticals made up 0.02% of Rothwell Investment Advisors, LLC's portfolio in Q3 2026, its #523 holding.
119 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q3 2026.

Based on Rothwell Investment Advisors, LLC's 13F filing for Q3 2026, filed 6 Nov 2026.